Institute For Wealth Management, Llc. Eli Lilly & CO Transaction History

Institute For Wealth Management, Llc.

$763 Million
Q1 2025

A detailed history of Institute For Wealth Management, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 6,166 shares of LLY stock, worth $4.98 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

6,166

Previous 6,380 3.35%

Holding current value

$4.98 Million

Previous $4.93 Million 3.39%

% of portfolio

0.67%

Previous 0.63%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	SELL	$725.72 - $929.72 $155,304 - $198,960	-214 Reduced 3.35%	6,166 $5.09 Million
Q4 2024 Jan 23, 2025	SELL	$727.2 - $932.06 $231,249 - $296,395	-318 Reduced 4.75%	6,380 $4.93 Million
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $124,314 - $154,563	161 Added 2.46%	6,698 $5.93 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $146,423 - $183,626	-202 Reduced 3.0%	6,537 $5.92 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $59,220 - $79,228	100 Added 1.51%	6,739 $5.24 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $66,173 - $78,010	-126 Reduced 1.86%	6,639 $3.87 Million
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $33,037 - $45,546	76 Added 1.14%	6,765 $3.63 Million
Q2 2023 Jul 25, 2023	SELL	$350.74 - $468.98 $8,417 - $11,255	-24 Reduced 0.36%	6,689 $3.14 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $62,436 - $73,328	-201 Reduced 2.91%	6,713 $2.31 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $14,791 - $17,234	-46 Reduced 0.66%	6,914 $2.53 Million
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $296 - $337	-1 Reduced 0.01%	6,960 $2.25 Million
Q2 2022 Jul 25, 2022	SELL	$278.73 - $327.27 $19,789 - $23,236	-71 Reduced 1.01%	6,961 $2.26 Million
Q4 2021 Jan 21, 2022	SELL	$224.85 - $279.04 $10,792 - $13,393	-48 Reduced 0.68%	7,032 $1.94 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $6,648 - $8,181	-30 Reduced 0.42%	7,080 $1.64 Million
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $20,402 - $26,390	113 Added 1.61%	7,110 $1.63 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $43,873 - $56,796	267 Added 3.97%	6,997 $1.31 Million
Q4 2020 Feb 01, 2021	BUY	$130.46 - $172.63 $86,625 - $114,626	664 Added 10.95%	6,730 $1.14 Million
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $155,431 - $179,785	-1,063 Reduced 14.91%	6,066 $898,000
Q2 2020 Jul 30, 2020	SELL	$136.42 - $164.18 $71,211 - $85,701	-522 Reduced 6.82%	7,129 $1.17 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $32,262 - $39,931	-271 Reduced 3.42%	7,651 $1.06 Million
Q4 2019 Feb 27, 2020	BUY	$106.92 - $132.43 $735,716 - $911,250	6,881 Added 661.0%	7,922 $1.04 Million
Q4 2019 Jan 27, 2020	SELL	$106.92 - $132.43 $752,289 - $931,777	-7,036 Reduced 87.11%	1,041 $1.04 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $307,021 - $333,960	-2,875 Reduced 26.25%	8,077 $903,000
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $12,740 - $14,871	-115 Reduced 1.04%	10,952 $1.21 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $1.23 Million - $1.45 Million	11,067 New	11,067 $1.44 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $1.28 Million - $1.43 Million	-12,085 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$85.86 - $107.31 $23,783 - $29,724	-277 Reduced 2.24%	12,085 $1.29 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $4,542 - $5,212	-60 Reduced 0.48%	12,362 $1.06 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $31,390 - $37,054	423 Added 3.53%	12,422 $1 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $114,306 - $122,606	-1,395 Reduced 10.42%	11,999 $1.01 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $32,446 - $36,012	421 Added 3.25%	13,394 $1.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,973	12,973 $1.06 Million

Others Institutions Holding LLY

# of Institutions

4,393

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $767B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institute For Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Institute For Wealth Management, Llc. with notifications on news.

Account

Institute For Wealth Management, Llc. Eli Lilly & CO Transaction History